Side population cells in human gallbladder cancer cell line GBC-SD regulated by TGF-ß-induced epithelial-mesenchymal transition

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 6, 2011, Pages 749-755

  Zhang, Zhifa ^a   Zhu, Feng ^a   Xiao, Ling ^b   Wang, Min ^a   Tian, Rui ^a   Shi, Chengjian ^a   Qin, Renyi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NAVAL UNIVERSITY OF ENGINEERING   (China)

Author keywords

Epithelial mesenchymal transition; Side population cells; Transforming growth factor

Indexed keywords

ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN;

ARTICLE; CYTOLOGY; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; GALLBLADDER TUMOR; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIDE POPULATION CELL; TUMOR CELL LINE;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GALLBLADDER NEOPLASMS; HUMANS; NEOPLASM PROTEINS; RNA, MESSENGER; SIDE-POPULATION CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84862914245     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0671-1     Document Type: Article

References (36)

1. Chan KM, Yeh TS, Yu MC, et al. Gallbladder carcinoma with biliary invasion: Clinical analysis of the differences from nonbiliary invasion. World J Surg, 2005,29(1):72-75
2. Kayahara M, Nagakawa T. Recent trends of gallbladder cancer in Japan: An analysis of 4,770 patients. Cancer, 2007,110(3):572-580 (Pubitemid 47106146)
3. Yee K, Sheppard BC, Domreis J, et al. Cancers of the gallbladder and biliary ducts. Oncology (Williston Park), 2002,16(7):939-946, 949; discussion 949-950, 952-953, 956-957
4. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res, 2007,67(3):1030-1037
5. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007,445(7123):106-110 (Pubitemid 46067310)
6. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature, 2001,414(6859):105-111 (Pubitemid 33041634)
7. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res, 2006,66(17):8319-8326 (Pubitemid 44449137)
8. Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res, 2009,69(18):7135-7139
9. Kudo-Saito C, Shirako H, Takeuchi T, et al. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell, 2009,15(3):195-206
10. Komuro A, Yashiro M, Iwata C, et al. Diffuse-type gastric carcinoma: Progression, angiogenesis, and transforming growth factor beta signaling. J Natl Cancer Inst, 2009,101(8):592-604
11. Kiyono K, Suzuki HI, Morishita Y, et al. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma. Cancer Sci, 2009,100(10):1809-1816
12. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003,425(6958):577-584 (Pubitemid 37280136)
13. Arumugam T, Ramachandran V, Fournier KF, et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res, 2009,69(14): 5820-5828
14. Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci, 2007,98(10):1512-1520 (Pubitemid 47308444)
15. Zavadil J, Bottinger EP. TGF-beta and epithelial-tomesenchymal transitions. Oncogene, 2005,24(37):5764-5774
16. Savagner P. Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays, 2001,23(10):912-923 (Pubitemid 32972691)
17. Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med, 1996,183(4): 1797-1806 (Pubitemid 26134320)
18. Yeh YC, Wang CZ, Tang MJ. Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity. J Cell Physiol, 2009,218(1):146-156
19. Wulf GG, Luo KL, Jackson KA, et al. Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica, 2003,88(4):368-378 (Pubitemid 36547122)
20. Goodell MA. Multipotential stem cells and "side population" cells. Cytotherapy, 2002,4(6):507-508 (Pubitemid 36050185)
21. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol, 2003,15(6): 740-746 (Pubitemid 37487967)
22. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2002,2(6):442-454
23. Ho MM, Ng AV, Lam S, et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res, 2007,67(10):4827-4833 (Pubitemid 46910191)
24. Miettinen PJ, Ebner R, Lopez AR, et al. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J Cell Biol, 1994,127(6 Pt 2):2021-2036
25. Gal A, Sjoblom T, Fedorova L, et al. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene, 2008,27(9): 1218-1230 (Pubitemid 351294691)
26. Roberts AB, Tian F, Byfield SD, et al. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev, 2006,17(1-2):19-27 (Pubitemid 43117513)
27. Saika S, Kono-Saika S, Tanaka T, et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest, 2004,84(10):1245-1258 (Pubitemid 40063691)
28. Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol, 2004,164(2):651-663 (Pubitemid 38364679)
29. Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest, 2003,112(10):1486- 1494 (Pubitemid 38056275)
30. Gauldie J, Kolb M, Ask K, et al. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc, 2006,3(8):696-702 (Pubitemid 44788227)
31. Zhao J, Shi W, Wang YL, et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol, 2002,282(3): L585-593 (Pubitemid 34654664)
32. Fukaya R, Ohta S, Yamaguchi M, et al. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett, 2010, 291(2):150-157
33. Kai K, D'Costa S, Yoon BI, et al. Characterization of side population cells in human malignant mesothelioma cell lines. Lung Cancer, 2010,70(2):146-151
34. Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 2006,24(3):506-513 (Pubitemid 44464754)
35. Mani SA, Guo W, Liao MJ, et al. The epithelial- mesenchymal transition generates cells with properties of stem cells. Cell, 2008,133(4):704-715 (Pubitemid 351636299)
36. Mishra L, Derynck R, Mishra B. Transforming growth factor-beta signaling in stem cells and cancer. Science, 2005,310(5745):68-71 (Pubitemid 41434534)